U.S. Minor Cannabinoids Market Size & Share Report, 2032

U.S. Minor Cannabinoids Market – By Type [Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC)], Product (Isolates, Distillate), Application (Pain Management, Neurological Disorders, Anxiety/Stress), End-use, Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increased consumer awareness and demand

3.2.1.2&nbsp;&nbsp;&nbsp; Expansion of product offerings

3.2.1.3&nbsp;&nbsp;&nbsp; Legalization and regulatory changes

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High production costs

3.2.2.2&nbsp;&nbsp;&nbsp; Advertising and marketing restrictions

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Future market trends

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Cannabigerol (CBG)

5.3&nbsp;&nbsp;&nbsp; Cannabinol (CBN)

5.4&nbsp;&nbsp;&nbsp; Cannabichromene (CBC)

5.5&nbsp;&nbsp;&nbsp; Tetrahydrocannabivarin (THCV)

5.6&nbsp;&nbsp;&nbsp; Cannabigerolic acid (CBGA)

5.7&nbsp;&nbsp;&nbsp; Other minor cannabinoids

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Isolates

6.3&nbsp;&nbsp;&nbsp; Distillate

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Pain management

7.3&nbsp;&nbsp;&nbsp; Neurological disorders

7.4&nbsp;&nbsp;&nbsp; Anxiety/stress

7.5&nbsp;&nbsp;&nbsp; Sleep disorders

7.6&nbsp;&nbsp;&nbsp; Joint pain &amp; inflammation

7.7&nbsp;&nbsp;&nbsp; Skin care

7.8&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-Use, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Pharmaceutical companies

8.3&nbsp;&nbsp;&nbsp; Cosmetic companies

8.4&nbsp;&nbsp;&nbsp; Other end-users

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Zone, 2021 - 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends, by zone

9.2&nbsp;&nbsp;&nbsp; Northeast

9.2.1&nbsp;&nbsp;&nbsp; Connecticut

9.2.2&nbsp;&nbsp;&nbsp; Maine

9.2.3&nbsp;&nbsp;&nbsp; Massachusetts

9.2.4&nbsp;&nbsp;&nbsp; New Hampshire

9.2.5&nbsp;&nbsp;&nbsp; Rhode Island

9.2.6&nbsp;&nbsp;&nbsp; Vermont

9.2.7&nbsp;&nbsp;&nbsp; New Jersey

9.2.8&nbsp;&nbsp;&nbsp; New York

9.2.9&nbsp;&nbsp;&nbsp; Pennsylvania

9.3&nbsp;&nbsp;&nbsp; East North Central

9.3.1&nbsp;&nbsp;&nbsp; Wisconsin

9.3.2&nbsp;&nbsp;&nbsp; Michigan

9.3.3&nbsp;&nbsp;&nbsp; Illinois

9.3.4&nbsp;&nbsp;&nbsp; Indiana

9.3.5&nbsp;&nbsp;&nbsp; Ohio

9.4&nbsp;&nbsp;&nbsp; West North Central

9.4.1&nbsp;&nbsp;&nbsp; North Dakota

9.4.2&nbsp;&nbsp;&nbsp; South Dakota

9.4.3&nbsp;&nbsp;&nbsp; Nebraska

9.4.4&nbsp;&nbsp;&nbsp; Kansas

9.4.5&nbsp;&nbsp;&nbsp; Minnesota

9.4.6&nbsp;&nbsp;&nbsp; Iowa

9.4.7&nbsp;&nbsp;&nbsp; Missouri

9.5&nbsp;&nbsp;&nbsp; South Atlantic

9.5.1&nbsp;&nbsp;&nbsp; Delaware

9.5.2&nbsp;&nbsp;&nbsp; Maryland

9.5.3&nbsp;&nbsp;&nbsp; District of Columbia

9.5.4&nbsp;&nbsp;&nbsp; Virginia

9.5.5&nbsp;&nbsp;&nbsp; West Virginia

9.5.6&nbsp;&nbsp;&nbsp; North Carolina

9.5.7&nbsp;&nbsp;&nbsp; South Carolina

9.5.8&nbsp;&nbsp;&nbsp; Georgia

9.5.9&nbsp;&nbsp;&nbsp; Florida

9.6&nbsp;&nbsp;&nbsp; East South Central

9.6.1&nbsp;&nbsp;&nbsp; Kentucky

9.6.2&nbsp;&nbsp;&nbsp; Tennessee

9.6.3&nbsp;&nbsp;&nbsp; Mississippi

9.6.4&nbsp;&nbsp;&nbsp; Alabama

9.7&nbsp;&nbsp;&nbsp; West South Central

9.7.1&nbsp;&nbsp;&nbsp; Oklahoma

9.7.2&nbsp;&nbsp;&nbsp; Texas

9.7.3&nbsp;&nbsp;&nbsp; Arkansas

9.7.4&nbsp;&nbsp;&nbsp; Louisiana

9.8&nbsp;&nbsp;&nbsp; Mountain States

9.8.1&nbsp;&nbsp;&nbsp; Idaho

9.8.2&nbsp;&nbsp;&nbsp; Montana

9.8.3&nbsp;&nbsp;&nbsp; Wyoming

9.8.4&nbsp;&nbsp;&nbsp; Nevada

9.8.5&nbsp;&nbsp;&nbsp; Utah

9.8.6&nbsp;&nbsp;&nbsp; Colorado

9.8.7&nbsp;&nbsp;&nbsp; Arizona

9.8.8&nbsp;&nbsp;&nbsp; New Mexico

9.9&nbsp;&nbsp;&nbsp; Pacific Central

9.9.1&nbsp;&nbsp;&nbsp; California

9.9.2&nbsp;&nbsp;&nbsp; Alaska

9.9.3&nbsp;&nbsp;&nbsp; Hawaii

9.9.4&nbsp;&nbsp;&nbsp; Oregon

9.9.5&nbsp;&nbsp;&nbsp; Washington

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; BayMedica (InMed Pharmaceuticals Inc.)

10.2&nbsp;&nbsp;&nbsp; Fresh Bros Hemp Company

10.3&nbsp;&nbsp;&nbsp; GVB Biopharma

10.4&nbsp;&nbsp;&nbsp; GenCanna

10.5&nbsp;&nbsp;&nbsp; KND Labs

10.6&nbsp;&nbsp;&nbsp; Laurelcrest

10.7&nbsp;&nbsp;&nbsp; Mile High Labs

10.8&nbsp;&nbsp;&nbsp; Open Book Extracts

10.9&nbsp;&nbsp;&nbsp; Rhizo Sciences

10.10&nbsp;&nbsp;&nbsp; Verus Extracts

10.11&nbsp;&nbsp;&nbsp; Viobin

10.12&nbsp;&nbsp;&nbsp; ZERO POINT EXTRACTION, LLC 
&nbsp;

US Minor Cannabinoids Market

Get a free sample of this report